Influenza Diagnostics Market : Table of Content


  • Published On : May-2020 |
  • Pages : 239 Pages |
  • Format : Influenza Diagnostics Market Influenza Diagnostics Market Influenza Diagnostics Market Influenza Diagnostics Market

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product type Innovation / Development Trends

4. Key Success Factors

    4.1. Influenza Diagnostics Adoption Rate/Usage Analysis- Key Statistics

    4.2. Key Promotional Strategies, By Key Manufacturers

    4.3. Key Regulations, By Region

    4.4. Disease Epidemiology

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        1.1.1. Global Healthcare Industry Market Outlook

        1.1.2. Global Life Science Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        1.1.3. Key Players Historical Growth

        1.1.4. Product Adoption Across Regions

        1.1.5. Product cost

        1.1.6. Disease Prevalence

        1.1.7. In-patient Statistics

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2020 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product

        6.4.2. Revenue By Country

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Influenza Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Test Type 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) By Test Type, 2015-2019

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test Type, 2020-2030

        8.3.1. Molecular Diagnostic Tests

            8.3.1.1. RT-PCR

            8.3.1.2. LAMP

            8.3.1.3. NASBA

        8.3.2. Traditional Diagnostic Tests

            8.3.2.1. Rapid Influenza Detection Tests

            8.3.2.2. Serological Assays

            8.3.2.3. Direct Fluorescent Antibody

            8.3.2.4. Viral Culture

            8.3.2.5. H1N1 Influenza A Virus Identification Kits

            8.3.2.6. Immunoassay Kits

            8.3.2.7. Immunofluorescence Antibody Assay

    8.4. Market Attractiveness Analysis By Test Type 

9. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu  

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) By Type of Flu , 2015-2019

    9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Type of Flu , 2020-2030

        9.3.1. Type A Flu

        9.3.2. Type B Flu

        9.3.3. Type C Flu

    9.4. Market Attractiveness Analysis By Test Type 

10. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By End User 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and By End User, 2015-2019

    10.3. Current and Future Market Size (US$ Mn) and Forecast By End User, 2020-2030

            10.3.1.1. Hospitals

            10.3.1.2. Diagnostic Laboratories 

            10.3.1.3. Research and Academic Institute 

            10.3.1.4. Contract research organization (CROs)

    10.4. Market Attractiveness Analysis by End User 

11. Global Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        12.3.1.  By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Test Type 

        12.3.3. By Type of Flu 

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        13.3.1.  By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Test Type 

        13.3.3. By Type of Flu 

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

        14.3.1.  By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Test Type 

        14.3.3. By Type of Flu 

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030

        15.3.1.  By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Test Type 

        15.3.3. By Type of Flu 

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Test Type 

        16.3.3. By Type of Flu 

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Test Type 

        17.3.3. By Type of Flu 

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030

        18.3.1.  By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. Rest of Middle East and Africa

        18.3.2. By Test Type 

        18.3.3. By Type of Flu 

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Influenza Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Influenza Diagnostics Market Analysis

        19.2.1. By Test Type

        19.2.2. By Type of Flu 

        19.2.3. By End User

    19.3. Canada Influenza Diagnostics Market Analysis

        19.3.1. By Test Type

        19.3.2. By Type of Flu 

        19.3.3. By End User

    19.4. Mexico Influenza Diagnostics Market Analysis

        19.4.1. By Test Type

        19.4.2. By Type of Flu 

        19.4.3. By End User

    19.5. Brazil Influenza Diagnostics Market Analysis

        19.5.1. By Test Type

        19.5.2. By Type of Flu 

        19.5.3. By End User

    19.6. U.K. Influenza Diagnostics Market Analysis

        19.6.1. By Test Type

        19.6.2. By Type of Flu 

        19.6.3. By End User

    19.7. Germany Influenza Diagnostics Market Analysis

        19.7.1. By Test Type

        19.7.2. By Type of Flu 

        19.7.3. By End User

    19.8. France Influenza Diagnostics Market Analysis

        19.8.1. By Test Type

        19.8.2. By Type of Flu 

        19.8.3. By End User

    19.9. Italy Influenza Diagnostics Market Analysis

        19.9.1. By Test Type

        19.9.2. By Type of Flu 

        19.9.3. By End User

    19.10. Spain Influenza Diagnostics Market Analysis

        19.10.1. By Test Type

        19.10.2. By Type of Flu 

        19.10.3. By End User

    19.11. BENELUX Influenza Diagnostics Market Analysis

        19.11.1. By Test Type

        19.11.2. By Type of Flu 

        19.11.3. By End User

    19.12. Russia Influenza Diagnostics Market Analysis

        19.12.1. By Test Type

        19.12.2. By Type of Flu 

        19.12.3. By Age Group

    19.13. China Influenza Diagnostics Market Analysis

        19.13.1. By Test Type

        19.13.2. By Type of Flu 

        19.13.3. By End User

    19.14. Japan Influenza Diagnostics Market Analysis

        19.14.1. By Test Type

        19.14.2. By Type of Flu 

        19.14.3. By End User

    19.15. South Korea Influenza Diagnostics Market Analysis

        19.15.1. By Test Type

        19.15.2. By Type of Flu 

        19.15.3. By End User

    19.16. India Influenza Diagnostics Market Analysis

        19.16.1. By Test Type

        19.16.2. By Type of Flu 

        19.16.3. By End User

    19.17. Indonesia Influenza Diagnostics Market Analysis

        19.17.1. By Test Type

        19.17.2. By Type of Flu 

        19.17.3. By End User

    19.18. Australia Influenza Diagnostics Market Analysis

        19.18.1. By Test Type

        19.18.2. By Type of Flu 

        19.18.3. By End User

    19.19. New Zealand Influenza Diagnostics Market Analysis

        19.19.1. By Test Type

        19.19.2. By Type of Flu 

        19.19.3. By End User

    19.20. GCC Countries Influenza Diagnostics Market Analysis

        19.20.1. By Test Type

        19.20.2. By Type of Flu 

        19.20.3. By End User

    19.21. Turkey Influenza Diagnostics Market Analysis

        19.21.1. By Test Type

        19.21.2. By Type of Flu 

        19.21.3. By End User

    19.22. South Africa Influenza Diagnostics Market Analysis

        19.22.1. By Test Type

        19.22.2. By Type of Flu 

        19.22.3. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies 

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

            20.3.1.1. Regional footprint of Players

            20.3.1.2. Product type foot print by Players

            20.3.1.3. Channel Foot Print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive 

        21.3.1. Abbott Laboratories

            21.3.1.1. Overview

            21.3.1.2. Product type Portfolio

            21.3.1.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Analyst Commentary

            21.3.1.6. Strategy Overview

                21.3.1.6.1. Marketing Strategy

                21.3.1.6.2. Product type Strategy

                21.3.1.6.3. Channel Strategy

        21.3.2. Endress+Hauser (Analytik Jena AG)

            21.3.2.1. Overview

            21.3.2.2. Product type Portfolio

            21.3.2.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Analyst Commentary

            21.3.2.6. Strategy Overview

                21.3.2.6.1. Marketing Strategy

                21.3.2.6.2. Product type Strategy

                21.3.2.6.3. Channel Strategy

        21.3.3. Becton, Dickinson and Company

            21.3.3.1. Overview

            21.3.3.2. Product type Portfolio

            21.3.3.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Analyst Commentary

            21.3.3.6. Strategy Overview

                21.3.3.6.1. Marketing Strategy

                21.3.3.6.2. Product type Strategy

                21.3.3.6.3. Channel Strategy

        21.3.4. Biocartis

            21.3.4.1. Overview

            21.3.4.2. Product type Portfolio

            21.3.4.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Analyst Commentary

            21.3.4.6. Strategy Overview

                21.3.4.6.1. Marketing Strategy

                21.3.4.6.2. Product type Strategy

                21.3.4.6.3. Channel Strategy

        21.3.5. bioMérieux Inc

            21.3.5.1. Overview

            21.3.5.2. Product type Portfolio

            21.3.5.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Analyst Commentary

            21.3.5.6. Strategy Overview

                21.3.5.6.1. Marketing Strategy

                21.3.5.6.2. Product type Strategy

                21.3.5.6.3. Channel Strategy

        21.3.6. Danaher Corporation (Cepheid)

            21.3.6.1. Overview

            21.3.6.2. Product type Portfolio

            21.3.6.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Analyst Commentary

            21.3.6.6. Strategy Overview

                21.3.6.6.1. Marketing Strategy

                21.3.6.6.2. Product type Strategy

                21.3.6.6.3. Channel Strategy

        21.3.7. F. Hoffmann-La Roche Ltd

            21.3.7.1. Overview

            21.3.7.2. Product type Portfolio

            21.3.7.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Analyst Commentary

            21.3.7.6. Strategy Overview

                21.3.7.6.1. Marketing Strategy

                21.3.7.6.2. Product type Strategy

                21.3.7.6.3. Channel Strategy

        21.3.8. GenMark Diagnostics, Inc.

            21.3.8.1. Overview

            21.3.8.2. Product type Portfolio

            21.3.8.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.8.4. Sales Footprint

            21.3.8.5. Analyst Commentary

            21.3.8.6. Strategy Overview

                21.3.8.6.1. Marketing Strategy

                21.3.8.6.2. Product type Strategy

                21.3.8.6.3. Channel Strategy

        21.3.9. Luminex Corporation

            21.3.9.1. Overview

            21.3.9.2. Product type Portfolio

            21.3.9.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.9.4. Sales Footprint

            21.3.9.5. Analyst Commentary

            21.3.9.6. Strategy Overview

                21.3.9.6.1. Marketing Strategy

                21.3.9.6.2. Product type Strategy

                21.3.9.6.3. Channel Strategy

        21.3.10. Meridian Bioscience, Inc

            21.3.10.1. Overview

            21.3.10.2. Product type Portfolio

            21.3.10.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.10.4. Sales Footprint

            21.3.10.5. Analyst Commentary

            21.3.10.6. Strategy Overview

                21.3.10.6.1. Marketing Strategy

                21.3.10.6.2. Product type Strategy

                21.3.10.6.3. Channel Strategy

        21.3.11. Quidel Corporation

            21.3.11.1. Overview

            21.3.11.2. Product type Portfolio

            21.3.11.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.11.4. Sales Footprint

            21.3.11.5. Analyst Commentary

            21.3.11.6. Strategy Overview

                21.3.11.6.1. Marketing Strategy

                21.3.11.6.2. Product type Strategy

                21.3.11.6.3. Channel Strategy

        21.3.12. Thermo Fisher Scientific Inc.

            21.3.12.1. Overview

            21.3.12.2. Product type Portfolio

            21.3.12.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.12.4. Sales Footprint

            21.3.12.5. Analyst Commentary

            21.3.12.6. Strategy Overview

                21.3.12.6.1. Marketing Strategy

                21.3.12.6.2. Product type Strategy

                21.3.12.6.3. Channel Strategy

        21.3.13. Hologic

            21.3.13.1. Overview

            21.3.13.2. Product type Portfolio

            21.3.13.3. Profitability by Market Segments (Product type/Channel/Region)

            21.3.13.4. Sales Footprint

            21.3.13.5. Analyst Commentary

            21.3.13.6. Strategy Overview

                21.3.13.6.1. Marketing Strategy

                21.3.13.6.2. Product type Strategy

                21.3.13.6.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology


List of Table 

Table 1: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 2: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 3: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 4: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 5: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 6: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 7: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 8: North America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 9: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 10: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 11: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 12: Latin America Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 13: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 14: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 15: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 16: Europe Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 17: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 18: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 19: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 20: South Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 21: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 22: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 23: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 24: East Asia Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 25: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 26: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 27: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 28: Oceania Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 29: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Test Type

Table 30: Global Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Type of Flu

Table 31: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

Table 32: Middle East and Africa Influenza Diagnostics Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country


List of Figures

Figure 1: Global Influenza Diagnostics Market Historical Market Value (US$ Mn) Analysis, 2015-2019

Figure 2: Global Influenza Diagnostics Current and Future Market Value (US$ Mn), 2020-2030 & Y-o-Y Growth Trend Analysis

Figure 3: Influenza Diagnostics Market Absolute $ Opportunity, 2020–2030

Figure 4: Global Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 5: Global Influenza Diagnostics Market Y-o-Y Growth (%) By Test Type, 2020-2030

Figure 6: Global Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 7: Global Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 8: Global Influenza Diagnostics Market Y-o-Y Growth (%) By Type of Flu, 2020-2030

Figure 9: Global Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 10: Global Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 11: Global Influenza Diagnostics Market Y-o-Y Growth (%) By End User, 2020-2030

Figure 12: Global Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 13: Global Influenza Diagnostics Market Share Analysis (%) By Region, 2020 & 2030

Figure 14: Global Influenza Diagnostics Market Y-o-Y Growth (%) By Region, 2020-2030

Figure 15: Global Influenza Diagnostics Market Attractiveness Analysis, By Region

Figure 16: North America Influenza Diagnostics Market Share, By Test Type (2019)

Figure 17: North America Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 18: North America Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 19: North America Influenza Diagnostics Market Share, By End User (2019)

Figure 20: North America Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 21: North America Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 22: North America Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 23: North America Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 24: North America Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 25: North America Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 26: Latin America Influenza Diagnostics Market Share, By Test Type (2019)

Figure 27: Latin America Influenza Diagnostics Market Share, By End User (2019)

Figure 28: Latin America Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 29: Latin America Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 30: Latin America Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 31: Latin America Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 32: Latin America Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 33: Latin America Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 34: Latin America Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 35: Latin America Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 36: Europe Influenza Diagnostics Market Share, By Test Type (2019)

Figure 37: Europe Influenza Diagnostics Market Share, By End User (2019)

Figure 38: Europe Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 39: Europe Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 40: Europe Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 41: Europe Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 42: Europe Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 43: Europe Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 44: Europe Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 45: Europe Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 46: South Asia Influenza Diagnostics Market Share, By Test Type (2019)

Figure 47: South Asia Influenza Diagnostics Market Share, By End User (2019)

Figure 48: South Asia Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 49: South Asia Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 50: South Asia Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 51: South Asia Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 52: South Asia Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 53: South Asia Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 54: South Asia Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 55: South Asia Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 56: East Asia Influenza Diagnostics Market Share, By Test Type (2019)

Figure 57: East Asia Influenza Diagnostics Market Share, By End User (2019)

Figure 58: East Asia Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 59: East Asia Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 60: East Asia Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 61: East Asia Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 62: East Asia Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 63: East Asia Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 64: East Asia Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 65: East Asia Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 66: Oceania Influenza Diagnostics Market Share, By Test Type (2019)

Figure 67: Oceania Influenza Diagnostics Market Share, By End User (2019)

Figure 68: Oceania Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 69: Oceania Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 70: Oceania Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 71: Oceania Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 72: Oceania Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 73: Oceania Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 74: Oceania Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 75: Oceania Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 76: Middle East and Africa Influenza Diagnostics Market Share, By Test Type (2019)

Figure 77: Middle East and Africa Influenza Diagnostics Market Share, By End User (2019)

Figure 78: Middle East and Africa Influenza Diagnostics Market Share, By Type of Flu (2019)

Figure 79: Middle East and Africa Influenza Diagnostics Market size (US$ Mn) 2020 & 2030

Figure 80: Middle East and Africa Influenza Diagnostics Market Value (US$ Mn) Analysis, 2015–2019

Figure 81: Middle East and Africa Influenza Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 82: Middle East and Africa Influenza Diagnostics Market Attractiveness Analysis, By Test Type

Figure 83: Middle East and Africa Influenza Diagnostics Market Attractiveness Analysis, By Type of Flu

Figure 84: Middle East and Africa Influenza Diagnostics Market Attractiveness Analysis, By End User

Figure 85: Middle East and Africa Influenza Diagnostics Market Attractiveness Analysis, By Country

Figure 86: U.S Market Value Proportion Analysis, 2020

Figure 87: U.S. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 88: U.S. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 89: U.S. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 90: Global Vs. U.S Growth Comparison

Figure 91: Canada Market Value Proportion Analysis, 2020

Figure 92: Canada. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 93: Canada. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 94: Canada. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 95: Global Vs. Canada Growth Comparison

Figure 96: Mexico Market Value Proportion Analysis, 2020

Figure 97: Mexico. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 98: Mexico. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 99: Mexico. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 100: Global Vs. Mexico Growth Comparison

Figure 101: Brazil Market Value Proportion Analysis, 2020

Figure 102: Brazil. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 103: Brazil. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 104: Brazil. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 105: Global Vs. Brazil Growth Comparison

Figure 106: U.K Market Value Proportion Analysis, 2020

Figure 107: U.K Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 108: U.K. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 109: U.K Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 110: Global Vs. U.K. Growth Comparison

Figure 111: Germany Market Value Proportion Analysis, 2020

Figure 112: Germany. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 113: Germany. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 114: Germany. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 115: Global Vs. Germany Growth Comparison

Figure 116: France Market Value Proportion Analysis, 2020

Figure 117: France. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 118: France. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 119: France. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 120: Global Vs. France Growth Comparison

Figure 121: Italy Market Value Proportion Analysis, 2020

Figure 122: Italy. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 123: Italy. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 124: Italy. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 125: Global Vs. Italy Growth Comparison

Figure 126: Spain Market Value Proportion Analysis, 2020

Figure 127: Spain. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 128: Spain. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 129: Spain. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 130: Global Vs. Spain Growth Comparison

Figure 131: BENELUX Market Value Proportion Analysis, 2020

Figure 132: BENELUX. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 133: BENELUX. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 134: BENELUX. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 135: Global Vs. BENELUX Growth Comparison

Figure 136: Russia Market Value Proportion Analysis, 2020

Figure 137: Russia. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 138: Russia. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 139: Russia. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 140: Global Vs. Russia Growth Comparison

Figure 141: China Market Value Proportion Analysis, 2020

Figure 142: China. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 143: China. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 144: China. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 145: Global Vs. China Growth Comparison

Figure 146: Japan Market Value Proportion Analysis, 2020

Figure 147: Japan. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 148: Japan. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 149: Japan. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 150: Global Vs. Japan Growth Comparison

Figure 151: South Korea Market Value Proportion Analysis, 2020

Figure 152: South Korea. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 153: South Korea. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 154: South Korea. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 155: Global Vs. South Korea Growth Comparison

Figure 156: India Market Value Proportion Analysis, 2020

Figure 157: India. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 158: India. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 159: India. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 160: Global Vs. India Growth Comparison

Figure 161: Indonesia Market Value Proportion Analysis, 2020

Figure 162: Indonesia. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 163: Indonesia. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 164: Indonesia. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 165: Global Vs. Indonesia Growth Comparison

Figure 166: Australia Market Value Proportion Analysis, 2020

Figure 167: Australia. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 168: Australia. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 169: Australia. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 170: Global Vs. Australia Growth Comparison

Figure 171: New Zealand Market Value Proportion Analysis, 2020

Figure 172: New Zealand. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 173: New Zealand. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 174: New Zealand. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 175: Global Vs. New Zealand Growth Comparison

Figure 176: GCC Countries Market Value Proportion Analysis, 2020

Figure 177: GCC Countries. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 178: GCC Countries. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 179: GCC Countries. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 180: Global Vs. GCC Countries Growth Comparison

Figure 181: Turkey Market Value Proportion Analysis, 2020

Figure 182: Turkey. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 183: Turkey. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 184: Turkey. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 185: Global Vs. Turkey Growth Comparison

Figure 186: South Africa Market Value Proportion Analysis, 2020

Figure 187: South Africa. Influenza Diagnostics Market Share Analysis (%) By Test Type, 2020 & 2030

Figure 188: South Africa. Influenza Diagnostics Market Share Analysis (%) By Type of Flu, 2020 & 2030

Figure 189: South Africa. Influenza Diagnostics Market Share Analysis (%) By End User, 2020 & 2030

Figure 190: Global Vs. South Africa Growth Comparison

Influenza Diagnostics Market - Table of Content

Back To Top